FindMyRecallSubscribe
Class I: serious health riskTerminated

Azurity Pharmaceuticals Zenzedi Recall

Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd

Azurity Pharmaceuticals, Inc. · Wilmington, MA

Risk level
Class I
Reported by FDA
Feb 7, 2024
Recall ID
D-0323-2024
Check your lot numberHow we source this data

Summary

Azurity Pharmaceuticals recalled Zenzedi starting Jan 4, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0323-2024 on Feb 7, 2024. Reason: Labeling: Label Mix-up. Status: Terminated.

Why it was recalled

Labeling: Label Mix-up

Product description

Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03

Lot numbers, UPCs & expiration codes

Lot # F230169A, Exp. 06/30/2025

Where it was sold

USA nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0323-2024
Classification
Class I
Status
Terminated
Recall initiated
Jan 4, 2024
FDA report date
Feb 7, 2024
Quantity
4,662 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Azurity Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0323-2024, exactly as published.

Show all FDA fields
City
Wilmington
State
MA
Status
Terminated
Country
United States
Event ID
93786
Address
841 Woburn St
Code information
Lot # F230169A, Exp. 06/30/2025
Postal code
01887-3414
Report date
Feb 7, 2024
Product type
Drugs
Recall number
D-0323-2024
Classification
Class I
Recalling firm
Azurity Pharmaceuticals, Inc.
Product quantity
4,662 bottles
Termination date
Sep 18, 2024
Reason for recall
Labeling: Label Mix-up
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03
Distribution pattern
USA nationwide
Recall initiation date
Jan 4, 2024
Initial firm notification
Letter
Center classification date
Feb 12, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0323-2024, published Feb 7, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls